PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2007 October; 8(4): 267–271.
Published online 2007 December 21. doi:  10.1208/pt0804113
PMCID: PMC2750699

Improved dissolution of oleanolic acid with ternary solid dispersions

Abstract

The purpose of this study was to enhance the dissolution of oleanolic acid by solid dispersions consisting of the drug, a polymeric carrier, and a surfactant. Binary solid dispersions consisting of oleanolic acid and polyvinylpyrrolidone were prepared for comparison. Polysorbate 80, a nonionic surfactant, was incorporated into binary solid dispersions as the third component to prepare ternary solid dispersions. Solid dispersions were characterized by differential scanning calorimetry, Fourier transform infrared spectroscopy, and dissolution tests. The crystallinization of OA was prohibited in solid dispersions. Both the binary and ternary solid dispersions enhanced the dissolution of OA. Moreover, the dissolution of ternary solid dispersion was faster compared with that of binary solid dispersion. Polysorbate 80 played an important positive role in dissolution of the solid dispersion.

Keywords: Oleanolic acid, ternary solid dispersions, PVPk30, Polysorbate 80

Full Text

The Full Text of this article is available as a PDF (298K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol. 1995;49:57–68. doi: 10.1016/0378-8741(95)90032-2. [PubMed] [Cross Ref]
2. Mahato SB, Sarkar SK, Poddar G. Triterpenoid saponins. Phytochemistry. 1988;27:3037–3067. doi: 10.1016/0031-9422(88)80001-3. [Cross Ref]
3. Tang HQ, Hu J, Yang L, et al. Terpenoids and flavonoids fromArtemisia species. Planta Med. 2000;66:391–393. doi: 10.1055/s-2000-8538. [PubMed] [Cross Ref]
4. Jeong TS, Hwang EI, Lee HB, et al. Chitin synthase II inhibitory activity of ursolic acid isolated fromCrataegus pinnatifida. Planta Med. 1999;65:261–263. doi: 10.1055/s-2006-960474. [PubMed] [Cross Ref]
5. Song M, Hang TJ, Wang Y, et al. Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry. J Pharm Biomed Anal. 2006;40:190–196. doi: 10.1016/j.jpba.2005.06.034. [PubMed] [Cross Ref]
6. Damian F, Blaton N, Naesens L, et al. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci. 2000;10:311–322. doi: 10.1016/S0928-0987(00)00084-1. [PubMed] [Cross Ref]
7. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971;60:1281–1302. doi: 10.1002/jps.2600600902. [PubMed] [Cross Ref]
8. Ford JL. The current status of solid dispersions. Pharm Acta Helv. 1986;61:69–88. [PubMed]
9. Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002;231:131–144. doi: 10.1016/S0378-5173(01)00891-2. [PubMed] [Cross Ref]
10. Abdul-Fattah AM, Bhargava HN. Preparation and in vitro evaluation of solid dispersions of halofantrine. Int J Pharm. 2002;235:17–33. doi: 10.1016/S0378-5173(01)00941-3. [PubMed] [Cross Ref]
11. Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2004;272:1–10. doi: 10.1016/j.ijpharm.2003.11.025. [PubMed] [Cross Ref]
12. Serajuddin ATM. Solid dispersion of poor water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88:1058–1066. doi: 10.1021/js980403l. [PubMed] [Cross Ref]
13. Serajuddin ATM, Sheen PC, Augustine MA. Improved dissolution of a poorly water-soluble drug from solid dispersions in poly (ethylene glycol): polysorbae 80 mixtures. J Pharm Sci. 1990;79:463–464. doi: 10.1002/jps.2600790524. [PubMed] [Cross Ref]
14. Morris KR, Knipp GT, Serajuddin ATM. Structural properties of poly (ethylene glycol)-polysorbate 80 mixture, a solid dispersion vehicle. J Pharm Sci. 1992;81:1185–1188. doi: 10.1002/jps.2600811212. [PubMed] [Cross Ref]
15. Wulff M, Alden M, Craig DQM. An investigation into the critical surfactant concentration for solid solubility of hydrophobic drug in different polyethylene glycols. Int J Pharm. 1996;142:189–198. doi: 10.1016/0378-5173(96)04669-8. [Cross Ref]
16. Mura P, Faucci MT, Manderioli A, et al. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev Ind Pharm. 1999;25:257–264. doi: 10.1081/DDC-100102169. [PubMed] [Cross Ref]
17. Dannenfelser RM, He H, Joshi Y, et al. Development of clinical dosage forms of a poorly water soluble drug I: application of polyethylene glycol-polysorbate80 solid dispersion carrier system. J Pharm Sci. 2004;93:1165–1175. doi: 10.1002/jps.20044. [PubMed] [Cross Ref]
18. Kearney AS, Gabriel DL, Mehta SC, et al. Effect of polyvinyl pyrrolidone on the crystallinity and dissolution rate of solid dispersions of the antiinflammatory Ci-987. Int J Pharm. 1994;104:169–174. doi: 10.1016/0378-5173(94)90192-9. [Cross Ref]
19. El-Zein H, Riad L, El-bary AA. Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation. Int J Pharm. 1998;168:209–220. doi: 10.1016/S0378-5173(98)00093-3. [Cross Ref]
20. USP . The United States Pharmacopeia (USP) XXIX. NF XXIV. Rockville, MD: United States Pharmacopeial Convention Inc.; 2006. pp. 2673–2673.
21. Matsumoto T, Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly-(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinylacetate) in relation to indomethacin crystallization. Pharm Res. 1999;16:1722–1728. doi: 10.1023/A:1018906132279. [PubMed] [Cross Ref]
22. Van den Mooter G, Wuyts M, Blaton N, et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci. 2001;12:261–269. doi: 10.1016/S0928-0987(00)00173-1. [PubMed] [Cross Ref]
23. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:54–55. [PubMed]
24. Okonogi S, Puttipipatkhachom S. Dissolution improvement of high drug-loaded solid dispersion.AAPS PharmSciTech. 2006;7:E52. [PMC free article] [PubMed]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists